RSS   Newsletter   Contact   Advertise with us
Post Online Media

Repros Therapeutics appoints Larry Dillaha as CEO

Repros TherapeuticsRepros Therapeutics, a development stage biopharmaceutical company, announced that it has appointed Larry Dillaha as president and chief executive officer.

Dr. Dillaha has been serving in these capacities on an interim basis since February 1, 2017. He has also been named to the Board.

Dr. Dillaha was previously the Chief Executive Officer of CavtheRx, an inception stage biotechnology company, and before that the Chief Operating Officer and Chief Medical Officer of New Haven Pharmaceuticals, a specialty pharmaceutical company.

He also served as Chief Medical Officer of Insys Therapeutics, Sciele Pharma and as Medical Director of Sanofi-Sythelabo.

Dr. Dillaha received an M.D. degree from the University of Tennessee, Memphis.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy